Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL). 
Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial. 
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy. 
Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma. 
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. 
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients. 
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy. 
Electrophysiological features of POEMS syndrome compared to MGUS-related neuropathy. 
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression. 
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.